印度2025年的GST 2.0改革削减了药品和医疗设备税,以提高医疗保健的可负担性。 India’s 2025 GST 2.0 reforms cut taxes on medicines and medical devices to boost healthcare affordability.

2025年9月22日生效的印度GST 2.0改革(GST 2.0)通过将药品和医疗设备税率降低至5%或18%(33种救生药物免税),简化了医疗税。 India’s GST 2.0 reforms, effective September 22, 2025, simplified healthcare taxation by lowering rates on medicines and medical devices to 5% or 18%, with 33 life-saving drugs exempt from tax. 诊断包、氧气、眼镜和绷带现在面临5%的费率,而医疗保险费则完全免付,提高了可负担性。 Diagnostic kits, oxygen, spectacles, and bandages now face a 5% rate, while health insurance premiums are fully exempt, improving affordability. 改革的目的是降低患者费用,增加获得护理的机会,尽管倒置的关税结构继续给制造商的现金流动造成压力。 The changes aim to reduce patient costs and enhance access to care, though an inverted duty structure continues to strain manufacturers’ cash flow.